How This Evidence Evolved
Dialysis Initiation Timing
Evidence against early dialysis initiation shifts focus to symptom-guided start
Timeline
Early observations and pilot data that first suggested a new direction
Timing of dialysis initiation, 2007 vs 1997: a mean 147 days earlier (95% CI 134-160); 233 days earlier (95% CI 206-267) in patients aged 75 or older
Adjusted risk of death by GFR at dialysis initiation, >10 vs <5 mL/min/1.73 m2: 42% higher (general population), 25% higher (aged 67+), 39% higher (low-risk subgroup)
Landmark RCTs and pivotal trials that established the evidence base
Follow-up studies, subgroup analyses, and real-world validation
Mortality HR by eGFR at hemodialysis start vs <5 mL/min/1.73 m2 (healthiest albumin group): 1.27 (5.0-9.9), 1.53 (10.0-14.9), 2.18 (15.0 or more)
Early dialysis starts (eGFR >10.5) in Canada after IDEAL publication: immediate rate ratio 0.874 (95% CI 0.818-0.933; P<.001)
Direct dialysis costs over median 4.15 years: early vs late start, $10,777 higher (95% CI $313-$22,801); quality-adjusted survival difference 0.02 full health equivalent years (95% CI -0.09 to 0.14)
Integration into clinical practice guidelines and recommendations
Consider dialysis for kidney-failure symptoms/signs, uncontrolled volume/BP, diet-refractory nutritional decline or cognitive impairment; not GFR alone (2B).
GFR <15 mL/min/1.73 m²: consider dialysis for uremic symptoms, uncontrolled fluid/BP or nutrition decline
Current standard of care and ongoing research directions
Landmark Trials in This Story
Trends in timing of initiation of chronic dialysis in the United States.
Timing of dialysis initiation, 2007 vs 1997: a mean 147 days earlier (95% CI 134-160); 233 days earlier (95% CI 206-267) in patients aged 75 or older
Effect of comorbidity on the increased mortality associated with early initiation of dialysis.
Adjusted risk of death by GFR at dialysis initiation, >10 vs <5 mL/min/1.73 m2: 42% higher (general population), 25% higher (aged 67+), 39% higher (low-risk subgroup)
A randomized, controlled trial of early versus late initiation of dialysis
All-cause mortality: HR 1.04 (95% CI 0.83-1.30; p=0.75); no benefit of early initiation
Early start of hemodialysis may be harmful.
Mortality HR by eGFR at hemodialysis start vs <5 mL/min/1.73 m2 (healthiest albumin group): 1.27 (5.0-9.9), 1.53 (10.0-14.9), 2.18 (15.0 or more)
Association Between the Publication of the Initiating Dialysis Early and Late Trial and the Timing of Dialysis Initiation in Canada
Early dialysis starts (eGFR >10.5) in Canada after IDEAL publication: immediate rate ratio 0.874 (95% CI 0.818-0.933; P<.001)
Cost-effectiveness of initiating dialysis early: a randomized controlled trial.
Direct dialysis costs over median 4.15 years: early vs late start, $10,777 higher (95% CI $313-$22,801); quality-adjusted survival difference 0.02 full health equivalent years (95% CI -0.09 to 0.14)
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.